semaglutide before and after 1 month Wegovy After: Real People, Real Results Semaglutide Weight Loss in Month

Regulatory Status and FDA Approval Timeline Current FDA Status (as of June 2026) The FDA has not approved retatrutide for any indication as of June 2026

The FDA then takes about 60 days to decide whether to accept the filing, and review after acceptance is typically 610 months (priority vs standard)

Some of the most popular GLP-1 agonists available by prescription are Ozempic, Wegovy, Mounjaro, and Zepbound

What works in month three may need adjustment by month eight

The realistic caveat is that long-term maintenance without pharmacologic or procedural support is difficult for most people which is the entire reason the rest of this list exists

And you might be interested to know that the FDA generally considers claims to treat or remove wrinkles and increase the skins production of collagen to be drug claims, which require the agencys approval